News Author: Jennifer Smith Publish date: December 20, 2019
ORLANDO – Progression-free survival results were best among complete responders and patients with primary mediastinal large B-cell lymphoma or tran...
News Author: Jennifer Smith Publish date: December 17, 2019
ORLANDO – Being older, male, and not having private insurance were some of the risk factors for intracranial hemorrhage among patients with immune ...
News Author: Jennifer Smith Publish date: December 16, 2019
The grants will support research on lung, breast, and bladder cancers.
News Author: Jennifer Smith Publish date: December 14, 2019
ORLANDO - The study raises the possibility of limited-duration, targeted-agent therapy in relapsed/refractory mantle cell lymphoma.
News Author: Jennifer Smith Publish date: December 14, 2019
ORLANDO – The CAR T-cell therapy produced the highest reported response rate in mantle cell lymphoma patients who have failed treatment with a Brut...
News Author: Jennifer Smith Publish date: December 12, 2019
ORLANDO – Orelabrutinib produced an 86% response rate in a phase 2 trial and appears to be safer than ibrutinib.
News Author: Jennifer Smith Publish date: December 10, 2019
ORLANDO – Rates of progression/relapse, progression-free survival, and overall survival were similar between posttransplant cyclophosphamide and im...
News Author: Jennifer Smith Publish date: December 9, 2019
ORLANDO – Preclinical research suggests it may be a fetal hemoglobin repressor.
News Author: Jennifer Smith Publish date: December 8, 2019
ORLANDO – Findings from this preclinical research support moving forward with a phase 1 study of the therapy, as monotherapy or combined with ritux...
Article Author: Jennifer Smith Publish date: December 2, 2019
Ten researchers will be honored at the 2019 annual meeting of the American Society of Hematology.
News Author: Jennifer Smith Publish date: November 25, 2019
NATIONAL HARBOR, MD. – In a phase 1/2 trial of previously untreated advanced melanoma patients, the combination of bempegaldesleukin and nivolumab ...
News Author: Jennifer Smith Publish date: November 18, 2019
NATIONAL HARBOR, MD. – Patients with TP53-mutated AML were shown to have increased immune infiltration, but it isn’t clear if they will respond wel...
News Author: Jennifer Smith Publish date: November 18, 2019
Dr. Brian Bolwell received the 2019 Alfred and Norma Lerner Humanitarian Award.
News Author: Jennifer Smith Publish date: November 15, 2019
Researchers are investigating gene variants and biomarkers that might correlate with chemotherapy-induced cognitive deficits.
News Author: Jennifer Smith Publish date: November 14, 2019
NATIONAL HARBOR, MD. – The vaccine produced only grade 1 adverse events and yielded responses in 7 of 24 patients, in...
